| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer
|
Han, Hye-Suk
|
|
2008
|
115 |
2 |
p. 335-342
|
artikel
|
| 2 |
A retrospective study of quality of life in a community sample of patients with early stage breast cancer
|
Walker, Mark S.
|
|
2009
|
115 |
2 |
p. 415-422
|
artikel
|
| 3 |
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy
|
Yang, Qifeng
|
|
2008
|
115 |
2 |
p. 343-348
|
artikel
|
| 4 |
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer
|
Xu, Xinran
|
|
2008
|
115 |
2 |
p. 397-404
|
artikel
|
| 5 |
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model
|
Zhou, Jiangbing
|
|
2008
|
115 |
2 |
p. 269-277
|
artikel
|
| 6 |
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
|
Yin, Wen-Jin
|
|
2008
|
115 |
2 |
p. 325-333
|
artikel
|
| 7 |
Cost-effective analyses in Breast Cancer Research and Treatment
|
Lippman, Marc E.
|
|
2009
|
115 |
2 |
p. 221-222
|
artikel
|
| 8 |
CYP2C19*17 is associated with decreased breast cancer risk
|
Justenhoven, Christina
|
|
2008
|
115 |
2 |
p. 391-396
|
artikel
|
| 9 |
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
|
Jacobi, Catharina E.
|
|
2008
|
115 |
2 |
p. 381-390
|
artikel
|
| 10 |
Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer
|
Çam, Ragip
|
|
2008
|
115 |
2 |
p. 431-432
|
artikel
|
| 11 |
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review
|
Flemming, Jennifer
|
|
2008
|
115 |
2 |
p. 255-268
|
artikel
|
| 12 |
High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations
|
Juan, Inmaculada de
|
|
2008
|
115 |
2 |
p. 405-414
|
artikel
|
| 13 |
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells
|
Lanzino, Marilena
|
|
2008
|
115 |
2 |
p. 297-306
|
artikel
|
| 14 |
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families
|
Hansen, Thomas v. O.
|
|
2008
|
115 |
2 |
p. 315-323
|
artikel
|
| 15 |
Link between insulin and metabolic disorders in cancer: does leptin play a key role?
|
Malandrino, Noemi
|
|
2008
|
115 |
2 |
p. 435-436
|
artikel
|
| 16 |
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
|
Spurdle, Amanda B.
|
|
2008
|
115 |
2 |
p. 307-313
|
artikel
|
| 17 |
Pattern of metastatic spread in triple-negative breast cancer
|
Dent, Rebecca
|
|
2008
|
115 |
2 |
p. 423-428
|
artikel
|
| 18 |
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers
|
Baak, Jan P. A.
|
|
2008
|
115 |
2 |
p. 241-254
|
artikel
|
| 19 |
Psychological impact of recall in high-risk breast MRI screening
|
O’Neill, Suzanne M.
|
|
2008
|
115 |
2 |
p. 365-371
|
artikel
|
| 20 |
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
|
Byrski, T.
|
|
2008
|
115 |
2 |
p. 359-363
|
artikel
|
| 21 |
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors
|
Brouckaert, Olivier
|
|
2008
|
115 |
2 |
p. 349-358
|
artikel
|
| 22 |
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones
|
Potter, Shirley M.
|
|
2008
|
115 |
2 |
p. 279-287
|
artikel
|
| 23 |
Terpenoids and breast cancer chemoprevention
|
Rabi, Thangaiyan
|
|
2008
|
115 |
2 |
p. 223-239
|
artikel
|
| 24 |
The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
|
Sikora, Matthew J.
|
|
2008
|
115 |
2 |
p. 289-296
|
artikel
|
| 25 |
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer
|
Bartsch, Rupert
|
|
2008
|
115 |
2 |
p. 373-380
|
artikel
|
| 26 |
The rising incidence of male breast cancer
|
Speirs, Valerie
|
|
2008
|
115 |
2 |
p. 429-430
|
artikel
|
| 27 |
The sensitivity of BRCA1 mutation carriers to ionising radiation: questions of methodology
|
Chechlinska, Magdalena
|
|
2008
|
115 |
2 |
p. 433
|
artikel
|
Tijdschrift beschrijving